Biomarkers Market - Global Industry Insights Health Articles | May 16 http://www.nashvillepredatorsteamstore.com/adidas-ryan-johansen-jersey , 2018

The research report on biomarkers market segments global by product type (Biomarker Test Kits, and Biomarker Analyzers), by disease indication (Cancer, Cardiovascular Disorder and Others), by application (Diagnosis, Drug Discovery, and Others ), by end user (Hospitals, Research Laboratories http://www.nashvillepredatorsteamstore.com/adidas-ryan-ellis-jersey ,) and by geography - Global Forecast to 2025



Biomarkers are the molecules used for diagnosis of diseases as these indicate normal or abnormal process in the body. Biomarkers can be any molecules such as DNA (genes), proteins or hormones that indicate about the health and can be classified on basis of different parameters, which includes characteristics such as imaging biomarkers or molecular biomarkers. Demand for biomarkers is increasing in drug discovery and development process, as use of biomarkers increases the success rate in drug development process, decrease costs, and improves patient outcome. Biomarkers also aid in predicting drug efficacy, quickly, than conventional clinical endpoints.


To understand Research Methodology, please click:

Furthermore http://www.nashvillepredatorsteamstore.com/adidas-roman-josi-jersey , biomarkers have the potential to substantially accelerate product development in certain disease areas. Biomarkers are also used in diagnosis of disorders related to chromosome structure, Turner syndrome, Down syndrome, Patau syndrome, Edwards’s syndrome, and others, which is expected to lead to increasing demand for biomarkers. For instance, in February 2018, FDA granted marketing authorization to Banyan Biomarkers http://www.nashvillepredatorsteamstore.com/adidas-pontus-aberg-jersey , Inc. for the first diagnostic blood test for traumatic brain injury, Banyan BTI. Such new innovations in biomarkers for various disease indication is expected to drive growth of the biomarkers market in the near future.


Moreover, pharmaceutical companies have started outsourcing the complex bio analysis not only to cut down costs, however, to take advantage of specialized expertise to improve efficiency in drug development process. For instance, in March 2018, the SenzaGen signed a key license agreement with Burlesson Research Technologies, Inc., (BRT)—a contract research organization in the U.S. http://www.nashvillepredatorsteamstore.com/adidas-pekka-rinne-jersey , specializing in immunotoxicology. This agreement, will provide BRTs 'GARD' to a broader market. GARD is a group of tests for assessing chemical sensitizers, where the test uses genetic biomarkers for over 200 genes, which cover an entire immune reaction and are relevant to predicting the risk of hypersensitivity. Such advancement and innovation by CROs is expected to favor growth of biomarkers market in the near future.


The biomarkers market is estimated to be valued at US$ 29,518.2 Mn in 2017 and is expected to witness a robust CAGR of 13.6% during the forecast period (2017-2025).


Increasing application of diagnostic application is expected to fuel growth of the global biomarkers market


Increasing application and awareness about biomarker tests is expected to be a major factor for growth of the market. Biomarkers are used for diagnostics and early detection of specific diseases over the conventional diagnostics methods. Furthermore, biomarkers such as BRCA1, indicates whether an individual has an increased likelihood of developing cancer. Biomarkers are also applied to a wide variety of therapeutic areas, which include neurological diseases, metabolic disorders http://www.nashvillepredatorsteamstore.com/adidas-p.k-subban-jersey , immune deregulation and oncology to treat various disease such as TMI, cancer, Alzheimer diagnosis. Biomarkers are also used to detect ABO haemolytic disease of new born, Huntington disease, and hereditary haemochromatosis, and cystic fibrosis.


Furthermore, biomarkers are used to detect disorder related to chromosome structure such as, Turner syndrome, Down syndrome http://www.nashvillepredatorsteamstore.com/adidas-nick-bonino-jersey , patau syndrome, Edwards’s syndrome, and others, which has led to increasing demand for biomarkers.


Increasing demand for precision medicine to drive the growth of the global biomarkers market


North America accounts for the largest share in the global biomarkers market and this is attributed to adoption of precision medicine and growing prevalence of cancer in the region. According to the National Cancer Institute, 2016, it was estimated that 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from cancer disease. The number of people suffering from cancer is expected to rise to 19 million by 2024, which supports increasing demand for precision medicine.


Ask for customization:

Furthermore http://www.nashvillepredatorsteamstore.com/adidas-miikka-salomaki-jersey , the U.S. government in 2015 announced the launch of Precision Medicine Initiative that aimed to revolutionize the treatment to improve health, as precision medicine is an innovative approach to offer tailored treatment. Precision